Control strategies for synthetic therapeutic peptide APIs – Part III: Manufacturing process considerations

Expert views
I. Eggen, B. Gregg, H. Rode, A. Swietlow, M. Verlander, A. Szajek; BioPharm International, 2014
Related posts
20 March 2025
13 November 2024